CS logo
small CS logo
UPMC Cancer Center at UPMC Horizon

Farrell, Pennsylvania, United States
Cancer treatment center in Farrell, Pennsylvania
2200 Memorial Dr, Farrell, PA 16121

About UPMC Cancer Center at UPMC Horizon


"UPMC Hillman Cancer Center - Farrell (Medical Oncology) is a Cancer Treatment Center located in Farrell.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
16
Alliance for Clinical Trials in Oncology
4
NRG Oncology
4
ECOG-ACRIN Cancer Research Group
3
SWOG Cancer Research Network
2
Canadian Cancer Trials Group
1
Total Rows: 6

Clinical Trials at UPMC Cancer Center at UPMC Horizon


During the past decade, UPMC Cancer Center at UPMC Horizon conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11001144889922110000110000000000Started TrialsCompleted Trails201520162017201820192020202120220510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
2012-06-04
2022-05-20
Completed
137
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
2013-03-18
2027-01-01
Recruiting
613
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
2017-09-12
2024-04-02
Active, not recruiting
700
BIOMARKER TRIAL of APALUTAMIDE and RADIATION for RECURRENT PROSTATE CANCER
2018-04-27
2028-10-31
Active, not recruiting
311
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
2018-02-01
2035-08-01
Active, not recruiting
897

Rows per page:

1–30 of 30

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "UPMC Cancer Center at UPMC Horizon" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "NRG Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center at UPMC Horizon" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 16National CancerInstitute (NCI): 16Alliance for ClinicalTrials in Oncology: 4Alliance for ClinicalTrials in Oncology: 4NRG Oncology: 4NRG Oncology: 4ECOG-ACRIN CancerResearch Group: 3ECOG-ACRIN CancerResearch Group: 3SWOG Cancer ResearchNetwork: 2SWOG Cancer ResearchNetwork: 2Canadian Cancer Trials Group: 1Canadian Cancer Trials Group: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 13National CancerInstitute (NCI): 13NRG Oncology: 5NRG Oncology: 5Alliance for ClinicalTrials in Oncology: 1Alliance for ClinicalTrials in Oncology: 1Canadian Cancer Trials Group: 1Canadian Cancer Trials Group: 1Eastern CooperativeOncology Group: 1Eastern CooperativeOncology Group: 1SWOG Cancer ResearchNetwork: 1SWOG Cancer ResearchNetwork: 1

Clinical Trials Conditions at UPMC Cancer Center at UPMC Horizon


According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center at UPMC Horizon" are "Stage III Lung Cancer AJCC v8" (4 trials), "Stage IIIA Lung Cancer AJCC v8" (4 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Prostate Adenocarcinoma" (3 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (3 trials). Many other conditions were trialed in "UPMC Cancer Center at UPMC Horizon" in a lesser frequency.

Clinical Trials Intervention Types at UPMC Cancer Center at UPMC Horizon


Most popular intervention types in "UPMC Cancer Center at UPMC Horizon" are "Drug" (25 trials), "Other" (21 trials), "Radiation" (17 trials), "Biological" (13 trials) and "Procedure" (12 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Cisplatin" (9 trials), "Computed Tomography" (9 trials), "Questionnaire Administration" (9 trials) and "Atezolizumab" (7 trials). Other intervention names were less common.

Clinical Trials Genders at UPMC Cancer Center at UPMC Horizon


The vast majority of trials in "UPMC Cancer Center at UPMC Horizon" are 25 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Clinical Trials Status at UPMC Cancer Center at UPMC Horizon


Currently, there are NaN active trials in "UPMC Cancer Center at UPMC Horizon". undefined are not yet recruiting, 21 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UPMC Cancer Center at UPMC Horizon, 3 suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UPMC Cancer Center at UPMC Horizon, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 20Phase 3: 20Phase 2: 17Phase 2: 17Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 21Recruiting: 21Active, not recruiting: 5Active, not recruiting: 5Suspended: 3Suspended: 3Completed: 1Completed: 1